©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

SPECTRALIS Q&A: Part 2
SPECTRALIS Q&A: Part 2

Karl Csaky, MD, PhD; Steve Thomas, CRA; Chris Wong

SPECTRALIS Q&A: Part 1
SPECTRALIS Q&A: Part 1

Karl Csaky, MD, PhD; Steve Thomas, CRA; Chris Wong

Easily Follow Patient Progression Utilizing Tools Available Within SPECTRALIS
Easily Follow Patient Progression Utilizing Tools Available Within SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

Variable Segmentation on Eyes With CNV with SPECTRALIS
Variable Segmentation on Eyes With CNV with SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

Enhanced Segmentation of OCTA Images with SPECTRALIS
Enhanced Segmentation of OCTA Images with SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

Expand Your Analysis of Abnormalities and Tissue Loss with SPECTRALIS
Expand Your Analysis of Abnormalities and Tissue Loss with SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

Novel C5 Inhibitor for GA Growth
Novel C5 Inhibitor for GA Growth

Karl Csaky, MD, PhD